Literature DB >> 32921951

Serum alkaline phosphatase is a prognostic marker in bone metastatic disease of the extremity.

Quirina C B S Thio1, Aditya V Karhade2, Emily Notman1, Kevin A Raskin2, Santiago A Lozano-Calderón2, Marco L Ferrone3, Jos A M Bramer1, Joseph H Schwab2.   

Abstract

PURPOSE: The purpose of this study was to determine the prognostic value of serum alkaline phosphatase for treatment decision making in metastatic bone disease.
METHODS: 1090 patients who underwent surgery for extremity metastatic disease were retrospectively identified at two tertiary care centers. The association between alkaline phosphatase and mortality was assessed by bivariate and multivariate analyses.
RESULTS: Three-month and one-year mortality rates were 305 (29%) and 639 (62%), respectively. Alkaline phosphatase was associated with mortality at both three months and one year.
CONCLUSION: Serum alkaline phosphatase may be a useful marker in prognostic algorithms for patients with extremity metastatic disease.
© 2020 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Biomarker; Bone metastasis; Prognostic factor; Survival

Year:  2020        PMID: 32921951      PMCID: PMC7475062          DOI: 10.1016/j.jor.2020.08.008

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  19 in total

1.  MissForest--non-parametric missing value imputation for mixed-type data.

Authors:  Daniel J Stekhoven; Peter Bühlmann
Journal:  Bioinformatics       Date:  2011-10-28       Impact factor: 6.937

2.  2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?

Authors:  Stein J Janssen; Andrea S van der Heijden; Maarten van Dijke; John E Ready; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2015-07-09       Impact factor: 4.176

Review 3.  Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker.

Authors:  Daniel Heinrich; Øyvind Bruland; Theresa A Guise; Hiroyoshi Suzuki; Oliver Sartor
Journal:  Future Oncol       Date:  2018-06-21       Impact factor: 3.404

4.  Serum alkaline phosphatase and 30-day mortality after surgery for spinal metastatic disease.

Authors:  Aditya V Karhade; Quirina C B S Thio; Paul T Ogink; Joseph H Schwab
Journal:  J Neurooncol       Date:  2018-09-01       Impact factor: 4.130

Review 5.  Diagnostic aspects of alkaline phosphatase and its isoenzymes.

Authors:  D W Moss
Journal:  Clin Biochem       Date:  1987-08       Impact factor: 3.281

Review 6.  Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis.

Authors:  Maire Ratasvuori; Rikard Wedin; Johnny Keller; Markus Nottrott; Olga Zaikova; Peter Bergh; Anders Kalen; Johan Nilsson; Halldor Jonsson; Minna Laitinen
Journal:  Surg Oncol       Date:  2013-04-04       Impact factor: 3.279

7.  The Social Security Death Index (SSDI) most accurately reflects true survival for older oncology patients.

Authors:  Justin T Huntington; Mathew Butterfield; James Fisher; Daniel Torrent; Mark Bloomston
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

8.  Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.

Authors:  Ying Jin; Mei-Qin Yuan; Jun-Qing Chen; Yi-Ping Zhang
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

9.  New prognostic factors and scoring system for patients with skeletal metastasis.

Authors:  Hirohisa Katagiri; Rieko Okada; Tatsuya Takagi; Mitsuru Takahashi; Hideki Murata; Hideyuki Harada; Tetsuo Nishimura; Hirofumi Asakura; Hirofumi Ogawa
Journal:  Cancer Med       Date:  2014-07-10       Impact factor: 4.452

10.  Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.

Authors:  Ping Huang; Min Lan; Ai-Fen Peng; Qing-Fu Yu; Wen-Zhao Chen; Zhi-Li Liu; Jia-Ming Liu; Shan-Hu Huang
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.